These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1937996

  • 1. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
    Bacracheva N, Scholl H, Gerova Z, Chervenakov P, Dobrev P, Vlahov V.
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration.
    Boothe DM, Boeckh A, Boothe HW, Wilkie S.
    Vet Ther; 2001 Sep; 2(2):120-8. PubMed ID: 19753704
    [Abstract] [Full Text] [Related]

  • 7. Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.
    Cole LK, Papich MG, Kwochka KW, Hillier A, Smeak DD, Lehman AM.
    Vet Dermatol; 2009 Feb; 20(1):51-9. PubMed ID: 19152587
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A, Martínez-Larrañaga MR, Díaz MJ, Fernández-Cruz ML, Martínez MA, Frejo MT, Martínez M, Iturbe J, Tafur M.
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Penetration of ciprofloxacin and its desethylenemetabolite into skin in humans after a single oral dose of the parent drug assessed by cutaneous microdialysis.
    Bielecka-Grzela S, Klimowicz A.
    J Clin Pharm Ther; 2005 Aug; 30(4):383-90. PubMed ID: 15985052
    [Abstract] [Full Text] [Related]

  • 14. Penetration of danofloxacin into the respiratory tract tissues and secretions in calves.
    Friis C.
    Am J Vet Res; 1993 Jul; 54(7):1122-7. PubMed ID: 8396371
    [Abstract] [Full Text] [Related]

  • 15. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
    Frost RW, Lettieri JT, Krol G, Shamblen EC, Lasseter KC.
    Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U, Sörgel F, Reiter A, Sigl G, Naber KG, Schunack W.
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.